Keros Therapeutics, Inc. (KROS)
USD 9.81
(-4.57%)
USD 9.81
(-4.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -316.7 Million USD | -19.16% |
| 2022 | -265.78 Million USD | -16.09% |
| 2021 | -228.94 Million USD | 13.6% |
| 2020 | -264.97 Million USD | -4512.31% |
| 2019 | -5.74 Million USD | 74.43% |
| 2018 | -22.47 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -428.23 Million USD | -35.22% |
| 2024 Q2 | -391.9 Million USD | 8.48% |
| 2023 Q2 | -308.07 Million USD | 8.7% |
| 2023 FY | -316.7 Million USD | -19.16% |
| 2023 Q4 | -316.7 Million USD | -15.76% |
| 2023 Q3 | -273.57 Million USD | 11.2% |
| 2023 Q1 | -337.43 Million USD | -26.96% |
| 2022 Q4 | -265.78 Million USD | -11.22% |
| 2022 Q3 | -238.97 Million USD | -11.17% |
| 2022 Q2 | -214.95 Million USD | 5.6% |
| 2022 Q1 | -227.7 Million USD | 0.54% |
| 2022 FY | -265.78 Million USD | -16.09% |
| 2021 Q3 | -220.05 Million USD | 6.92% |
| 2021 Q1 | -254.4 Million USD | 3.99% |
| 2021 FY | -228.94 Million USD | 13.6% |
| 2021 Q2 | -236.42 Million USD | 7.07% |
| 2021 Q4 | -228.94 Million USD | -4.04% |
| 2020 Q3 | -132.81 Million USD | 7.51% |
| 2020 Q1 | -53.33 Million USD | -828.34% |
| 2020 Q2 | -143.59 Million USD | -169.24% |
| 2020 FY | -264.97 Million USD | -4512.31% |
| 2020 Q4 | -264.97 Million USD | -99.51% |
| 2019 Q4 | -5.74 Million USD | 0.0% |
| 2019 FY | -5.74 Million USD | 74.43% |
| 2019 Q1 | 23.25 Million USD | 0.0% |
| 2018 FY | -22.47 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -466.148% |
| Alkermes plc | -166.73 Million USD | -89.939% |
| Agenus Inc. | 274.13 Million USD | 215.528% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 116.937% |
| Aptorum Group Limited | 1.35 Million USD | 23437.676% |
| Ardelyx, Inc. | 34.51 Million USD | 1017.661% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 7499.603% |
| Bicycle Therapeutics plc | -481.46 Million USD | 34.221% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 975.765% |
| ChromaDex Corporation | -24.04 Million USD | -1216.962% |
| Chimerix, Inc. | -25.51 Million USD | -1141.145% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 4645.057% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1237.598% |
| CRISPR Therapeutics AG | -150.84 Million USD | -109.953% |
| Precision BioSciences, Inc. | -85.41 Million USD | -270.803% |
| Dyadic International, Inc. | -6.37 Million USD | -4865.476% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1887.717% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4231.807% |
| Lantern Pharma Inc. | -21.7 Million USD | -1359.24% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -186.513% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -3607.087% |
| Incyte Corporation | -3.17 Billion USD | 90.025% |
| IO Biotech, Inc. | -140.69 Million USD | -125.093% |
| Jaguar Health, Inc. | 29.39 Million USD | 1177.551% |
| Novavax, Inc. | -298.29 Million USD | -6.171% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 6034.102% |
| Opthea Limited | 28.15 Million USD | 1224.758% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1786.372% |
| ContextLogic Inc. | -232 Million USD | -36.51% |
| MiMedx Group, Inc. | -33.9 Million USD | -834.2% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3206.454% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -13568.507% |
| NextCure, Inc. | -6.47 Million USD | -4789.656% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -527.122% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -4864.775% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2703.766% |
| Vaxcyte, Inc. | -368.22 Million USD | 13.992% |
| PDS Biotechnology Corporation | -32.7 Million USD | -868.247% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1932.984% |
| Pharming Group N.V. | 109.8 Million USD | 388.426% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1720.551% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -80.736% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1610.073% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1610.073% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -4360.606% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -5304.488% |
| Acelyrin, Inc. | -216.9 Million USD | -46.011% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -5545.061% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -18270.244% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1013.373% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -4555.343% |
| Senti Biosciences, Inc. | 1.74 Million USD | 18301.322% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -71.555% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -308.908% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -5124.398% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 317536.278% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 50530.414% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -170.58% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -88.253% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 385.653% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -4069.339% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -145.289% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 4693.495% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -30.673% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1708.719% |
| MEI Pharma, Inc. | -3.7 Million USD | -8447.989% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2631.396% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 295.808% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1239.506% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4231.807% |
| Precigen, Inc. | -481 Thousand USD | -65742.62% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2349.151% |
| AlloVir, Inc. | -62.69 Million USD | -405.173% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -469.466% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 613.578% |
| ImmuCell Corporation | 10.99 Million USD | 2981.591% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -105.457% |
| Onconetix, Inc. | 5.33 Million USD | 6040.293% |
| PureTech Health plc | -167.19 Million USD | -89.419% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -939.734% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1556.57% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -6351.477% |
| Seer, Inc. | -4.24 Million USD | -7369.41% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1217.565% |
| Innoviva, Inc. | 255.56 Million USD | 223.924% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -466.918% |
| ESSA Pharma Inc. | -33.62 Million USD | -841.963% |
| GlycoMimetics, Inc. | -40.98 Million USD | -672.74% |
| GT Biopharma, Inc. | -1.02 Million USD | -30918.903% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -367.231% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 617.007% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -136.206% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2185.674% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -996.921% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -420298.492% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -926.191% |
| Aptose Biosciences Inc. | -8.19 Million USD | -3764.656% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -10021.482% |
| Soligenix, Inc. | -4.95 Million USD | -6295.977% |
| Century Therapeutics, Inc. | 847 Thousand USD | 37491.145% |
| Kura Oncology, Inc. | -20.11 Million USD | -1474.227% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -673.843% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -3671.172% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 17485.073% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -9806.256% |
| Autolus Therapeutics plc | -186.59 Million USD | -69.724% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -542.347% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -14.833% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1024.195% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 292.679% |
| GRI Bio, Inc. | -1.79 Million USD | -17553.456% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3425.564% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -852.29% |
| IGM Biosciences, Inc. | -72.6 Million USD | -336.194% |
| INmune Bio, Inc. | -25.41 Million USD | -1146.322% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 309.805% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -525.166% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1849.017% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -10877.855% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 933.1% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -668.977% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1093.266% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 183.795% |
| Verastem, Inc. | -37.27 Million USD | -749.571% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3390.61% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -510.665% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1992.521% |
| Histogen Inc. | -7.48 Million USD | -4130.039% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1365.755% |
| Surrozen, Inc. | -32.66 Million USD | -869.578% |
| Organovo Holdings, Inc. | -1.5 Million USD | -20915.461% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -7434.291% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1770.356% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 12206.384% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 7720.38% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -3678.754% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -629.025% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -2072.642% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 0.027% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -43761.036% |
| Apollomics, Inc. | -27.39 Million USD | -1056.061% |
| Amarin Corporation plc | -191.04 Million USD | -65.778% |
| Mesoblast Limited | 55.96 Million USD | 665.915% |
| Turnstone Biologics Corp. | -14.58 Million USD | -2071.578% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1152.186% |
| Synaptogenix, Inc. | -28.66 Million USD | -1004.977% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -33735.791% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 749.887% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -36636.694% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -4258.65% |
| Exelixis, Inc. | -73.05 Million USD | -333.543% |
| Better Therapeutics, Inc. | -860 Thousand USD | -36725.93% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1218.881% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -31.21% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 43126.441% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -4157.828% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 25355.423% |
| Gritstone bio, Inc. | 39.49 Million USD | 901.983% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -276.575% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -11932.149% |
| Avid Bioservices, Inc. | 169.72 Million USD | 286.594% |
| Insmed Incorporated | 721.62 Million USD | 143.888% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3364.449% |
| MediWound Ltd. | -5.32 Million USD | -5850.827% |
| OmniAb, Inc. | 9.2 Million USD | 3541.302% |
| Alector, Inc. | -35.63 Million USD | -788.692% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 468.384% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -6326.603% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2492.197% |
| Zai Lab Limited | -775 Million USD | 59.135% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 192.996% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1371.326% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -283.976% |
| Immunic, Inc. | -45.34 Million USD | -598.507% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -63.912% |
| Veracyte, Inc. | -203.82 Million USD | -55.381% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 149.617% |
| FibroGen, Inc. | 56.76 Million USD | 657.9% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3656.463% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -11102.47% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -15197.09% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 106.899% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -9379.288% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -90.826% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1873.055% |
| Galecto, Inc. | -21.21 Million USD | -1392.755% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1231.524% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 120.18% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1194.144% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2652.264% |
| XBiotech Inc. | -200.02 Million USD | -58.333% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -276.575% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 7094.324% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -798.117% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -310.141% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 5664.98% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -85.842% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -242.849% |
| Vaxxinity, Inc. | 10.13 Million USD | 3225.77% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 143.015% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2841.272% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -380.173% |
| NexImmune, Inc. | -3.13 Million USD | -10006.544% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -9072.69% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1995.782% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1068.646% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -3428.31% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -254126.771% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -680.595% |
| Ainos, Inc. | 4.07 Million USD | 7866.272% |
| Pluri Inc. | 22.82 Million USD | 1487.284% |
| Prothena Corporation plc | -608.34 Million USD | 47.94% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -166.684% |
| Celularity Inc. | 65.19 Million USD | 585.815% |
| Rallybio Corporation | -24.1 Million USD | -1214.011% |
| Cue Biopharma, Inc. | -33.81 Million USD | -836.465% |
| MeiraGTx Holdings plc | -40.3 Million USD | -685.825% |
| Omeros Corporation | 331.17 Million USD | 195.63% |
| Humacyte, Inc. | -22.48 Million USD | -1308.445% |
| Immunocore Holdings plc | -358.59 Million USD | 11.682% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1188.72% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -924.896% |
| Blueprint Medicines Corporation | 702.83 Million USD | 145.061% |
| CalciMedica, Inc. | -5.53 Million USD | -5626.998% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -68.262% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -3000.676% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -691.026% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -852.404% |
| Pulmatrix, Inc. | -10.41 Million USD | -2940.252% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -5198.695% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -730.326% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -184.288% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -428.331% |
| Cytokinetics, Incorporated | 642.37 Million USD | 149.302% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -5338.829% |
| Nutriband Inc. | -251.65 Thousand USD | -125747.086% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -828.231% |
| Vor Biopharma Inc. | 4.3 Million USD | 7465.186% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 94.753% |
| Evogene Ltd. | -19.63 Million USD | -1513.034% |
| ProKidney Corp. | -56.23 Million USD | -463.168% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -550.688% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3328.565% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 123.22% |
| CorMedix Inc. | -43.05 Million USD | -635.62% |
| BioLineRx Ltd. | 7.33 Million USD | 4417.107% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1053.115% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 786.292% |
| Atai Life Sciences N.V. | -28.55 Million USD | -1008.982% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 14298.56% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1288.074% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1885.751% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -321.854% |
| MediciNova, Inc. | -50.78 Million USD | -523.633% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -301.882% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1407781.752% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4808.154% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -58.493% |
| Biomea Fusion, Inc. | -166.57 Million USD | -90.132% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -76.954% |
| Mereo BioPharma Group plc | -51.46 Million USD | -515.328% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -233.92% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -7.81% |
| Absci Corporation | -72.59 Million USD | -336.242% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 7036.115% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -35.091% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -236.164% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -230.947% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -710.542% |
| Allakos Inc. | -24.97 Million USD | -1168.08% |
| Imunon, Inc. | -4.21 Million USD | -7415.76% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -2048.304% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -133.902% |
| BioAtla, Inc. | -109.01 Million USD | -190.524% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 43126.441% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -33627.689% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2746.691% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1393.671% |
| XOMA Corporation | -29 Million USD | -992.079% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1812.458% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3412.677% |
| aTyr Pharma, Inc. | -7.44 Million USD | -4151.618% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -154.102% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -52.141% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -287.267% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -241.411% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -36760.905% |
| Akari Therapeutics, Plc | -3.84 Million USD | -8136.749% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 19614.755% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 122.935% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -26555.473% |
| UroGen Pharma Ltd. | 4.39 Million USD | 7312.548% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 379.08% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 440197.551% |
| Orgenesis Inc. | 21.78 Million USD | 1553.833% |
| Entera Bio Ltd. | -10.62 Million USD | -2879.612% |
| GH Research PLC | -78.07 Million USD | -305.629% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1320.957% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1087.978% |
| Xencor, Inc. | 29.64 Million USD | 1168.354% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -15977.829% |
| Replimune Group, Inc. | 1.41 Million USD | 22529.391% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -129215.09% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -150.522% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -26555.473% |
| Portage Biotech Inc. | -4.98 Million USD | -6258.221% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1407781.752% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -378.968% |
| OncoCyte Corporation | -6.56 Million USD | -4725.583% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 35390.663% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -6851.884% |
| Purple Biotech Ltd. | -14.13 Million USD | -2140.083% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1233.15% |
| scPharmaceuticals Inc. | -6.54 Million USD | -4738.854% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1797.315% |
| HilleVax, Inc. | -165.48 Million USD | -91.379% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -12378.448% |
| Tharimmune, Inc. | -10.93 Million USD | -2796.139% |
| Genprex, Inc. | -6.73 Million USD | -4600.511% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 14.128% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -258.018% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -22505.496% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -9448.03% |
| OKYO Pharma Limited | -826.84 Thousand USD | -38202.445% |
| Savara Inc. | 153 Thousand USD | 207095.425% |
| Curis, Inc. | -23.88 Million USD | -1225.838% |
| Daré Bioscience, Inc. | -5.15 Million USD | -6040.141% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -40711.611% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -5001.53% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 26825.992% |
| BeiGene, Ltd. | -2.25 Billion USD | 85.944% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2666.787% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 47.928% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -70.65% |
| Erasca, Inc. | -37.21 Million USD | -750.986% |
| bluebird bio, Inc. | 108.57 Million USD | 391.701% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -24490.785% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 183.618% |
| DBV Technologies S.A. | -126.98 Million USD | -149.4% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -24490.785% |
| Moderna, Inc. | -2.9 Billion USD | 89.106% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2959.341% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2814.087% |
| Molecular Templates, Inc. | 707 Thousand USD | 44895.332% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -909.541% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 191.372% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -285.931% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -245.256% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -881.355% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -821.291% |
| MacroGenics, Inc. | -66.98 Million USD | -372.797% |
| RenovoRx, Inc. | -1.17 Million USD | -26899.403% |
| Adicet Bio, Inc. | -138.78 Million USD | -128.194% |
| Prime Medicine, Inc. | -27.94 Million USD | -1033.471% |
| Aditxt, Inc. | 18.12 Million USD | 1847.724% |
| Adagene Inc. | -87.62 Million USD | -261.42% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -7503.132% |
| Quantum-Si incorporated | -118.55 Million USD | -167.131% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 979.608% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -4137.29% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -552.875% |
| SciSparc Ltd. | -2.06 Million USD | -15236.707% |
| Vericel Corporation | 1.27 Million USD | 24900.548% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2541.018% |
| Minerva Neurosciences, Inc. | 41 Million USD | 872.366% |
| Generation Bio Co. | 31.44 Million USD | 1107.069% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -80.598% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -924.166% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 371.631% |
| Invivyd, Inc. | -198.47 Million USD | -59.567% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -250.84% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -13108.681% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -347.384% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -4540.337% |
| 2seventy bio, Inc. | 181.71 Million USD | 274.286% |
| ADMA Biologics, Inc. | 90.06 Million USD | 451.634% |
| Clene Inc. | 3.34 Million USD | 9582.126% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3386.881% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1372.284% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4808.154% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 7.968% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1118.103% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 278.258% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -7640.384% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 6431.527% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -5979.919% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -143.049% |
| Evaxion Biotech A/S | 5.28 Million USD | 6090.398% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -181.344% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -141.255% |
| Trevena, Inc. | 2.25 Million USD | 14125.819% |
| Surrozen, Inc. | -32.66 Million USD | -869.578% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -514.838% |
| Cingulate Inc. | 3.08 Million USD | 10373.616% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -10683.214% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 4506.609% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3308.624% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -299.257% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -140.927% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -200.073% |
| Clearmind Medicine Inc. | -3.94 Million USD | -7932.771% |
| Kronos Bio, Inc. | -36.05 Million USD | -778.413% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3465.958% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 21819.85% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -483.72% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2296.824% |
| ImmunityBio, Inc. | 618.22 Million USD | 151.228% |
| Korro Bio, Inc. | -132.94 Million USD | -138.225% |
| Kineta, Inc. | -4.54 Million USD | -6874.301% |
| BioVie Inc. | -17.73 Million USD | -1686.018% |
| Codexis, Inc. | -43.27 Million USD | -631.906% |
| Celularity Inc. | 65.19 Million USD | 585.815% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -9893.784% |
| Celcuity Inc. | 6.78 Million USD | 4768.719% |
| Virax Biolabs Group Limited | -3.36 Million USD | -9311.836% |
| Cibus, Inc. | -8.07 Million USD | -3820.562% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -7388.839% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 7030.044% |
| IN8bio, Inc. | -16.38 Million USD | -1832.412% |
| Kodiak Sciences Inc. | -103.87 Million USD | -204.889% |
| Annexon, Inc. | -193.75 Million USD | -63.455% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 879830.556% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1709.835% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -8915.172% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 130.04% |
| Eyenovia, Inc. | 1.25 Million USD | 25261.079% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1277.116% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -9665.742% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -852.576% |
| Arcellx, Inc. | -296.95 Million USD | -6.649% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1523.618% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -437.924% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1427.973% |
| Moolec Science SA | 117.61 Thousand USD | 269368.637% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -724.769% |
| Geron Corporation | 14.76 Million USD | 2245.539% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -735.231% |
| Royalty Pharma plc | 5.65 Billion USD | 105.597% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -123.943% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -4431.175% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -5805.488% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -125.041% |
| Humacyte, Inc. | -22.48 Million USD | -1308.445% |
| Structure Therapeutics Inc. | -124.33 Million USD | -154.709% |
| 89bio, Inc. | -289.05 Million USD | -9.566% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1154.667% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -17662.367% |
| Genelux Corporation | -6.89 Million USD | -4490.564% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -919.682% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 478.836% |
| Notable Labs, Ltd. | -9.77 Million USD | -3139.597% |
| Liquidia Corporation | -80.17 Million USD | -295.01% |
| Mustang Bio, Inc. | -3.73 Million USD | -8377.061% |
| Immunovant, Inc. | -635.22 Million USD | 50.143% |
| Quantum-Si incorporated | -118.55 Million USD | -167.131% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1703.137% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -7544.292% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 4045.472% |
| Acasti Pharma Inc. | -23 Million USD | -1276.67% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -9305.449% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1849.017% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -129.928% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -10062.587% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1324.537% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1605.547% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -87.09% |
| PepGen Inc. | -60.67 Million USD | -422.009% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1278.408% |
| United Therapeutics Corporation | -507.7 Million USD | 37.62% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1555.877% |
| Solid Biosciences Inc. | -47.75 Million USD | -563.252% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -36636.694% |
| Immuneering Corporation | -54.94 Million USD | -476.423% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -7434.291% |
| Silo Pharma, Inc. | -3.52 Million USD | -8886.246% |
| Belite Bio, Inc | -87.27 Million USD | -262.896% |
| XOMA Corporation | -29 Million USD | -992.079% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -347.972% |
| Bionomics Limited | 227 Million USD | 239.511% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -172.358% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -12403.079% |
| uniQure N.V. | -102.95 Million USD | -207.625% |
| Cassava Sciences, Inc. | -121.13 Million USD | -161.444% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -7503.132% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 873.371% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2547.797% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -10135.376% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 298876.415% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -9665.742% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3656.463% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -4170.537% |
| Altimmune, Inc. | -134.48 Million USD | -135.49% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 259.899% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -12403.079% |
| Compugen Ltd. | -12.9 Million USD | -2354.301% |
| Peak Bio, Inc. | 10.34 Million USD | 3162.845% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -111809.187% |
| Benitec Biopharma Inc. | -50.58 Million USD | -526.118% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -203.536% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1712.13% |
| Zura Bio Limited | -99.8 Million USD | -217.319% |
| PolyPid Ltd. | 6.17 Million USD | 5232.95% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 527.284% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1712.13% |
| Instil Bio, Inc. | 75.35 Million USD | 520.265% |
| argenx SE | -2.02 Billion USD | 84.39% |
| Immunome, Inc. | -97.02 Million USD | -226.4% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1307.882% |
| Verona Pharma plc | -220.44 Million USD | -43.667% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -341.441% |
| Shattuck Labs, Inc. | -121.42 Million USD | -160.824% |
| CervoMed Inc. | -7.79 Million USD | -3964.022% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -70.73% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -7142.236% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -140.4% |
| Moolec Science SA | 117.61 Thousand USD | 269368.637% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -13742.053% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 2092.046% |
| AnaptysBio, Inc. | -18.15 Million USD | -1644.824% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1644.92% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -349.984% |
| NeurAxis, Inc. | 145.7 Thousand USD | 217466.507% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2919.649% |
| Lumos Pharma, Inc. | -28.49 Million USD | -1011.512% |
| Achilles Therapeutics plc | -126.92 Million USD | -149.522% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -341.441% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -48197.775% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1424.529% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 21819.85% |
| Nutriband Inc. | -251.65 Thousand USD | -125747.086% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2304.548% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -4156.761% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 193.094% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1434.329% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 29.224% |
| Palisade Bio, Inc. | -12.06 Million USD | -2525.408% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -125.715% |
| Beam Therapeutics Inc. | -262.72 Million USD | -20.547% |
| Neurogene Inc. | -131.95 Million USD | -140.008% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1551.701% |
| AEON Biopharma, Inc. | -4.88 Million USD | -6389.816% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 16.036% |
| Sesen Bio, Inc. | -112.55 Million USD | -181.381% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -217.147% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -13389.392% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -711.518% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -280.278% |
| Athira Pharma, Inc. | -88.99 Million USD | -255.85% |
| Vaccinex, Inc. | -1.28 Million USD | -24488.742% |
| HCW Biologics Inc. | 2.85 Million USD | 11186.417% |
| XOMA Corporation | -29 Million USD | -992.079% |
| Nektar Therapeutics | 210.24 Million USD | 250.639% |
| Arvinas, Inc. | -313.8 Million USD | -0.925% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 19614.755% |
| Merus N.V. | -192.88 Million USD | -64.194% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 627.97% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -4464.759% |
| Rezolute, Inc. | -68.16 Million USD | -364.592% |
| Clene Inc. | 3.34 Million USD | 9582.126% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2301.63% |
| BeyondSpring Inc. | -13.75 Million USD | -2202.457% |
| Synlogic, Inc. | -6.68 Million USD | -4637.517% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 28027.954% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -3645.748% |
| Peak Bio, Inc. | 10.34 Million USD | 3162.845% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -284.255% |
| Krystal Biotech, Inc. | -350.23 Million USD | 9.574% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 355.148% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -87.403% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -9931.313% |
| MannKind Corporation | 143.89 Million USD | 320.087% |
| Ikena Oncology, Inc. | -109.15 Million USD | -190.138% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -4083.107% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -856.807% |
| Gossamer Bio, Inc. | 180.35 Million USD | 275.6% |
| CohBar, Inc. | -5.93 Million USD | -5240.033% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -964.619% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 7036.115% |
| Legend Biotech Corporation | -949.39 Million USD | 66.642% |
| Mural Oncology plc | -255.84 Million USD | -23.788% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1083.092% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -6623.139% |
| Disc Medicine, Inc. | -358.28 Million USD | 11.605% |
| Champions Oncology, Inc. | 4.81 Million USD | 6681.525% |
| REGENXBIO Inc. | 54.76 Million USD | 678.263% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -117674.175% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -109.704% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3414.234% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -292.528% |
| Vaxart, Inc. | -8.24 Million USD | -3743.017% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -531.134% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -149.048% |
| Cellectis S.A. | -43.85 Million USD | -622.159% |
| Longeveron Inc. | -2.9 Million USD | -10790.75% |
| Repare Therapeutics Inc. | -107.85 Million USD | -193.63% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 132.704% |
| Inozyme Pharma, Inc. | 12 Million USD | 2738.312% |
| Revolution Medicines, Inc. | -608.2 Million USD | 47.928% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -25648.211% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -19.458% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -111.034% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1924.049% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -42697.703% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.689% |
| Denali Therapeutics Inc. | -74.86 Million USD | -323.032% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2541.018% |
| Veru Inc. | 4.77 Million USD | 6725.629% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2716.139% |
| Cingulate Inc. | 3.08 Million USD | 10373.616% |
| Passage Bio, Inc. | 4.58 Million USD | 7007.372% |
| Context Therapeutics Inc. | -14.44 Million USD | -2091.743% |
| Exicure, Inc. | 5.84 Million USD | 5514.652% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -37.472% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -700.361% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 2118.374% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -438.418% |
| Nuvalent, Inc. | -335.38 Million USD | 5.571% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 18360.711% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -325.207% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3462.463% |
| OmniAb, Inc. | 9.2 Million USD | 3541.302% |
| Anew Medical, Inc. | 1.43 Million USD | 22208.952% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 2033.267% |
| Lipocine Inc. | -4.75 Million USD | -6560.992% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -188.363% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2179.332% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -525.166% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1372.308% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -4612.141% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -381.114% |
| Ocugen, Inc. | -32.52 Million USD | -873.842% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -270.088% |
| Q32 Bio Inc. | -37.94 Million USD | -734.571% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -50330.414% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2240.92% |
| Equillium, Inc. | -22.39 Million USD | -1314.358% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1138.669% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -870.685% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -127646.607% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 336.271% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 10003.158% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 96526.147% |
| Dominari Holdings Inc. | 195 Thousand USD | 162511.795% |
| Edesa Biotech, Inc. | -5.26 Million USD | -5913.07% |
| vTv Therapeutics Inc. | -8.91 Million USD | -3451.677% |
| Bio-Techne Corporation | 267.74 Million USD | 218.284% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1853.871% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -168.179% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -3668.928% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2403.383% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -29.204% |
| Nkarta, Inc. | 57.29 Million USD | 652.72% |
| BioCardia, Inc. | 212 Thousand USD | 149488.208% |
| Iterum Therapeutics plc | 13.43 Million USD | 2456.772% |